Evidence map›Paper›PMID 28739540›Full record

Trial reportContemporary clinical trials2017

The women in steady exercise research (WISER) survivor trial: The innovative transdisciplinary design of a randomized controlled trial of exercise and weight-loss interventions among breast cancer survivors with lymphedema.

Renate M Winkels, Kathleen M Sturgeon, Michael J Kallan, Lorraine T Dean, Zi Zhang, Margaret Evangelisti, Justin C Brown, David B Sarwer, Andrea B Troxel, Crystal Denlinger and 5 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Contemporary clinical trials, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01515124 (The Women In Steady Exercise Research), which is not on this map. Cited by 28 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 5 pooled it
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01515124 nacompletednot on this map

The Women In Steady Exercise Research (WISER) Survivor Trial & Cost of Illness and Cost Effectiveness of Alternative Management Strategies

TypeinterventionalSponsorMilton S. Hershey Medical CenterRan2012 to 2016Enrolled450ConditionsLymphedemaArmsExercise Intervention, Weight Loss Intervention
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 5 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Body weight management in overweight and obese breast cancer survivors.The Cochrane database of systematic reviews · 2020
    Pooled it
  4. Resistance exercise and breast cancer-related lymphedema-a systematic review update and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Pooled it
  5. Pooled it
  6. Evaluating the relationship between physical activity and quality of life in a racially diverse sample of breast cancer survivors.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 2 countries.

Renate M WinkelsDepartment of Public Health Sciences, Pennsylvania State University, Hershey, PA, United States.
Kathleen M SturgeonDepartment of Public Health Sciences, Pennsylvania State University, Hershey, PA, United States.
Michael J KallanCenter for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, United States.
Lorraine T DeanDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Zi ZhangCenter for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, United States.
Margaret EvangelistiCenter for Human Phenomic Science, University of Pennsylvania, Philadelphia, PA, United States.
Justin C BrownDivision of Population Sciences, Dana Farber Cancer Institute, Boston, MA, United States.
David B SarwerCenter for Obesity Research and Education, College of Public Health, Temple University, Philadelphia, PA, United States.
Andrea B TroxelDepartment of Population Health, New York University School of Medicine, New York City, NY, United States.
Crystal DenlingerDepartment of Hematology/Oncology, Fox Chase Cancer Centre, Philadelphia, PA, United States.
Monica LaudermilkEXOS, Phoenix, AZ, United States.
Anna FornashCenter for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, United States.
Angela DeMicheleDivision of Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Lewis A ChodoshDepartment of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Kathryn H SchmitzDepartment of Public Health Sciences, Pennsylvania State University, Hershey, PA, United States. Electronic address: kschmitz@phs.psu.edu.
University of Pennsylvania · USPennsylvania State University · USDana-Farber Cancer Institute · USExos (United States) · USFox Chase Cancer Center · USJohns Hopkins University · USNew York University · USTemple University · US

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI ALAN KEITH MEEKER · 1985 to 2026
$208.6M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Anna Palmer Durbin · 2012 to 2026
$67.0M
The Women In Steady Exercise Research (WISER) SurwVor TrialU54CA155850 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SCHMITZ, KATHRYN H. · 2011 to 2015
$9.1M
The Brown Initiative in HIV and AIDS Clinical Research for Minority CommunitiesR25MH083620 · NIMH · MIRIAM HOSPITAL · PI NUNN, AMY STEWART · 2008 to 2025
$3.7M
Social Determinants of Breast Cancer SurvivorshipK01CA184288 · NCI · UNIVERSITY OF PENNSYLVANIA · PI DEAN, LORRAINE TIERA · 2014 to 2018
$767k
NCI NIH HHS K01 CA184288NCI NIH HHS P30 CA006973NCI NIH HHS U54 CA155850NIAID NIH HHS P30 AI094189NIMH NIH HHS R25 MH083620
6 · The paper itself

Abstract

introductionBreast cancer survivors face dual challenges: long term sequelae of treatment, and risk of recurrent disease. Obesity and a sedentary lifestyle complicate both challenges. The WISER Survivor trial assessed the effects of exercise and/or weight-loss on lymphedema, biomarkers of breast cancer recurrence, and quality of life. We report on the innovative transdisciplinary design of this trial and report attrition rates.

methodsThis one year trial randomized breast cancer survivors who had a BMI of ≥25kg/m RESULTS & DISCUSSION: 351 participants were randomized; 13 experienced breast cancer recurrence during the trial. Of the 338 participants without recurrence, 83% completed the trial. The WISER Survivor trial will show the effects of exercise and weight-loss on lymphedema outcomes, biomarkers of recurrence and quality of life. NCT ClinicalTrials.gov registration #: NCT01515124.

Indexed as

Cancer SurvivorsExerciseAdultAgedAged, 80 and overBiomarkers, TumorBreast NeoplasmsCost-Benefit AnalysisDiet, ReducingFemaleHumansLife StyleLymphedemaMiddle AgedNeoplasm Recurrence, LocalObesityBiomarkers, TumorBiomarkersBreast cancerLymphedemaRelapse

Identifiers

PMID28739540
PMCPMC5817634
OpenAlexW2738765264

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.